These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9477128)

  • 1. High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia.
    Woolley I; Curtis D; Szer J; Fairley C; Vujovic O; Ugoni A; Spelman D
    Leuk Lymphoma; 1997 Nov; 27(5-6):469-74. PubMed ID: 9477128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study.
    Sallah S; Wan JY; Nguyen NP; Vos P; Sigounas G
    Cancer; 2001 Sep; 92(6):1349-53. PubMed ID: 11745210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
    Insiripong S; Thaisamakr S
    J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior uveitis associated with high-dose cytosine arabinoside.
    Fintelmann RE; Qian Y; Skalet A; Jeng BH
    Ocul Immunol Inflamm; 2010 Dec; 18(6):485-7. PubMed ID: 20887203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Dose Cytosine Arabinoside in the consolidation of adult acute myeloid leukemia.
    Rahman MH; Khan MA; Islam MS; Afrose S; Ara T
    Mymensingh Med J; 2012 Apr; 21(2):213-9. PubMed ID: 22561761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
    Bradley AM; Deal AM; Buie LW; van Deventer H
    Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.
    Ozkan A; Apak H; Celkan T; Yüksel L; Yildiz I
    Pediatr Dermatol; 2001; 18(1):38-40. PubMed ID: 11207969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
    Pellier I; Leboucher B; Rachieru P; Ifrah N; Rialland X
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis.
    Bainschab A; Quehenberger F; Greinix HT; Krause R; Wölfler A; Sill H; Zebisch A
    Leuk Res; 2016 Mar; 42():47-51. PubMed ID: 26866663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity.
    Bleyer A
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):274. PubMed ID: 17414574
    [No Abstract]   [Full Text] [Related]  

  • 12. Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy.
    Amaki J; Onizuka M; Ohmachi K; Aoyama Y; Hara R; Ichiki A; Kawai H; Sato A; Miyamoto M; Toyosaki M; Machida S; Kojima M; Shirasugi Y; Kawada H; Ogawa Y; Ando K
    Int J Hematol; 2015 Jun; 101(6):543-53. PubMed ID: 25735499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent cerebellar toxicity of cytosine arabinoside (Ara C) in a young woman.
    Friedman JH; Shetty N
    Mov Disord; 2001 May; 16(3):575-7. PubMed ID: 11391764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
    Avramis VI; Wiersma S; Krailo MD; Ramilo-Torno LV; Sharpe A; Liu-Mares W; Kowck R; Reaman GH; Sato JK
    Clin Cancer Res; 1998 Jan; 4(1):45-52. PubMed ID: 9516951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosine arabinoside-induced vasculitis.
    Ahmed I; Chen KR; Nakayama H; Gibson LE
    Mayo Clin Proc; 1998 Mar; 73(3):239-42. PubMed ID: 9511781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe anterior uveitis as a complication of high-dose cytosine-arabinoside.
    Moberg J; Carlsson M; Holm C; Koranyi G
    Acta Ophthalmol; 2009 Nov; 87(8):922-3. PubMed ID: 19799589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatosplenic candidiasis in acute myeloid leukemia].
    Larregina A; Bartoletti B; Romano H; Paniccia L; Polini NN
    Rev Argent Microbiol; 2004; 36(1):28-30. PubMed ID: 15176375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatosplenic candidiasis in acute leukaemia patients].
    Rajić Z; Colović N; Sretenović M; Plecić M; Janković S; Bakrac M; Colović M
    Srp Arh Celok Lek; 2008; 136(7-8):414-8. PubMed ID: 18959179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
    Wolach O; Itchaki G; Bar-Natan M; Yeshurun M; Ram R; Herscovici C; Shpilberg O; Douer D; Tallman MS; Raanani P
    Hematol Oncol; 2016 Mar; 34(1):28-35. PubMed ID: 25689584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.